TNF alpha (TNF) Mouse Monoclonal Antibody [Clone ID: OTI5A11]

CAT#: TA807821

TNFA mouse monoclonal antibody,clone OTI5A11

Product Images

HEK293T cells were transfected with the pCMV6-ENTRY control (middle lane) or pCMV6-ENTRY TNFA (RC206983, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) and Origene recombinant TNFA protein TP750007 (0.6ug, left lane) were separated by SDS-PAGE and immunoblotted with anti-TNFA (1:2000). Positive lysates LY424626 (100ug) and LC424626 (20ug) can be purchased separately from OriGene.

• 

  ELISA anaylysis of anti-TNFA antibody. 96-well plate was coated with Origene recombinant protein TNFa (TP750007) and primary antibody dilution ranges from 1:100 to 1:10000 (TA807821, 1mg/ml).

Specifications

Product Data

• Clone Name: OTI5A11
• Applications: IF, WB
• Recommended Dilution: WB 1:2000, IF 1:100
• Reactivities: Human
• Host: Mouse
• Isotype: IgG1
• Clonality: Monoclonal
• Immunogen: Full length human recombinant protein of human TNFA (NP_000585) produced in HEK293T cell.
• Formulation: PBS (pH 7.3) containing 1% BSA, 50% glycerol and 0.02% sodium azide.
• Concentration: 1 mg/ml
• Purification: Purified from mouse ascites fluids or tissue culture supernatant by affinity chromatography (protein A/G)
• Conjugation: Unconjugated
• Storage: Store at -20°C as received.
• Stability: Stable for 12 months from date of receipt.
• Predicted Protein Size: 25.5 kDa
• Gene Name: tumor necrosis factor
• Database Link:
  NP_000585
  Entrez Gene 7124 Human
  UniProt ID P01375
• Synonyms: DIF; TNF-alpha; TNFA; TNFSF2

Reference Data

• Protein Families: Druggable Genome, Secreted Protein, Transcription Factors, Transmembrane
• Protein Pathways: Adipocytokine signaling pathway, Allograft rejection, Alzheimer's disease, Amyotrophic lateral sclerosis (ALS), Apoptosis, Asthma, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Fc epsilon RI signaling pathway, Graft-versus-host disease, Hematopoietic cell lineage, Hypertrophic cardiomyopathy (HCM), MAPK signaling pathway, Natural killer cell mediated cytotoxicity, NOD-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, Toll-like receptor signaling pathway, Type I diabetes mellitus, Type II diabetes mellitus